{"id":"NCT02047227","sponsor":"Merck KGaA, Darmstadt, Germany","briefTitle":"Phase 3 Study to Evaluate the Efficacy and Safety of Pergoveris® in Assisted Reproductive Technology (ESPART)","officialTitle":"A Phase III, Randomized, Controlled, Single-blind, Multicentre, Parallel Arm Trial to Assess the Efficacy and Safety of Pergoveris® (Follitropin Alfa and Lutropin Alfa) and GONAL-f® (Follitropin Alfa) for Multifollicular Development as Part of an Assisted Reproductive Technology Treatment Cycle in Poor Ovarian Responders, as Defined by the European Society of Human Reproduction and Embryology Criteria","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-01-31","primaryCompletion":"2015-08-31","completion":"2015-08-31","firstPosted":"2014-01-28","resultsPosted":"2017-01-24","lastUpdate":"2017-08-24"},"enrollment":939,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"TREATMENT"},"conditions":["Infertility"],"interventions":[{"type":"DRUG","name":"Pergoveris®","otherNames":["r-hFSH/r-hLH","Follitropin alfa/Lutropin alfa"]},{"type":"DRUG","name":"GONAL-f®","otherNames":["r-hFSH","Follitropin alfa"]},{"type":"DRUG","name":"Recombinant human chorionic gonadotrophin (r-hCG)","otherNames":["Ovidrel®","Ovitrelle®","choriogonadotropin alfa"]}],"arms":[{"label":"Pergoveris®","type":"EXPERIMENTAL"},{"label":"GONAL-f®","type":"ACTIVE_COMPARATOR"}],"summary":"This is a Phase 3, randomized, controlled, single-blind, multicenter, parallel-arm trial to assess the safety and efficacy of Pergoveris® (recombinant human follicle stimulating hormone \\[r-hFSH\\]/recombinant human luteinising hormone \\[r-hLH\\]) and GONAL-f® for multifollicular development as part of an assisted reproductive technology (ART) treatment cycle in poor ovarian responders, as aligned with the 2011 Consensus Meeting of the European Society of Human Reproduction and Embryology (ESHRE) criteria.","primaryOutcome":{"measure":"Number of Oocytes Retrieved","timeFrame":"At approximately 34 to 38 hours after r-hCG administration (Day 113)","effectByArm":[{"arm":"Pergoveris","deltaMin":3.3,"sd":2.71},{"arm":"GONAL-f","deltaMin":3.6,"sd":2.82}],"pValues":[{"comp":"OG000 vs OG001","p":"0.054"}]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":8,"exclusionCount":10},"locations":{"siteCount":1,"countries":["Germany"]},"refs":{"pmids":["28137754","26141305"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":8,"n":462},"commonTop":["Headache","Hot flush","Nausea","Abdominal pain","Abortion spontaneous"]}}